Results 181 to 190 of about 3,771,869 (289)

Integrative bioinformatics approach to the mRNA vaccine development for the human papillomavirus using the capsid protein. [PDF]

Biol Direct
He S, Zubair A, Ahmad F, Shahani MY, Zeng L, Afghan N.   +5 more
europepmc   +1 more source

Ant–aphid mutualism: the influence of Tapinoma ibericum (Hymenoptera: Formicidae) on Aphis gossypii (Hemiptera: Aphidae) control by commercial and spontaneous natural enemies

Insect Science, EarlyView.
The mutualism between Tapinoma ibericum ants and Aphis gossypii disrupts the biological control exerted by Aphidius colemani in greenhouse peppers. Ant exclusion increased parasitism and the presence of most natural enemies, although Aphidoletes aphidimyza was more abundant with ants.
Jesús Foronda, Estefanía Rodríguez, Mónica González, María del Mar Téllez, Carmen Robles‐Vallet, Pablo Barranco, Felipe Pascual, Francisca Ruano   +7 more
wiley   +1 more source

Cyclophilin A stabilizes the capsid protein p72 to facilitate African swine fever virus replication. [PDF]

Nat Commun
Kong H, Yang L, Zhang Z, Zhang Y, Liu L, Wang W, Song L, Zhu Y, Sun E, Li F, Bu Z, Sheng X, Zhao D.   +12 more
europepmc   +1 more source

Clinical Features and Predictors of Hospital Stay in Paediatric Epstein–Barr Virus Infectious Mononucleosis: A Multicentre Cohort Study

Acta Paediatrica, EarlyView.
ABSTRACT Aim To describe age‐specific clinical features and identify predictors of length of hospital stay in children and adolescents with primary Epstein–Barr virus (EBV) infectious mononucleosis (IM). Methods This multicentre retrospective cohort study included all children and adolescents aged 0–17 years with a verified primary EBV infection in the
Lasse H. Nyhegn, Sara Yde Steffensen, Sabine Frølich Maarbjerg, Luise Borch, Marianne Kragh Thomsen, Mette Holm   +5 more
wiley   +1 more source

Herpes Simplex Virus Type 1 (HSV-1) UL38 Capsid Protein: A Promising Target Against Viral Infection. [PDF]

Viruses
Sofianidi AA, Spiliopoulos FG, Papavassiliou KA, Papavassiliou AG.   +3 more
europepmc   +1 more source

Performance of point‐of‐care tests for diagnosing feline immunodeficiency virus infection in captive African lions (Panthera leo)

Australian Veterinary Journal, EarlyView.
Point‐of‐care (PoC) antibody (Ab) testing forms an integral component of feline immunodeficiency virus (FIV) diagnosis in both domestic and non‐domestic felids, with test kits designed for use in domestic cats frequently extrapolated for use in their wild counterparts. The SNAP® FIV/FeLV Combo lateral flow ELISA is commonly used to assign FIV infection
SE Jobbins, ME Westman, K Vinette Herrin, T Meili, R Hofmann‐Lehmann, JM Norris   +5 more
wiley   +1 more source

Degraders of the dengue virus capsid protein exhibit differentiated pharmacology relative to capsid inhibitors. [PDF]

Nat Commun
Chakravarty A, Wang LN, Golden RP, Li Z, Donovan KA, Afanzar O, Zhang Y, Fischer ES, Gray NS, Yang PL.   +9 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

A single residue in the VP3 capsid protein governs virulence and informs live-attenuated vaccine design for coxsackievirus A6. [PDF]

J Virol
Liu K, Liu Z, Yan X, Yang Z, Li X, Zhang C.   +5 more
europepmc   +1 more source

Challenges in Gene‐Directed Therapies for Rare Neurodevelopmental Disorders Using HNRNPU as an Exemplar

Clinical Genetics, EarlyView.
Beyond diagnosing rare neurodevelopmental disorders like HNRNPU‐RNDD, developing gene‐directed therapies requires overcoming complex hurdles, including spatial, developmental, and cell‐type constraints. Addressing these requires understanding the molecular effects of dosage and chromatin dynamics to deliver precise, effective treatments.
Daniel Aiyedun, Susan F. Rogers, Doaa M. Taha, Meena Balasubramanian   +3 more
wiley   +1 more source